Developmental Neurobiology Panel
Aim
The aim of the Developmental Neurobiology Panel is to identify the key neurodevelopmental processes that are aberrant in schizophrenia and to understand how variation in susceptibility genes and susceptibility environments both independently and interactively impact these neurodevelopmental processes.
This will be achieved by identifying important gaps in our knowledge base and supporting research using animal models, human brain, neural cell culture and genomics that aims to fill those gaps. The Panel will develop and support collaborative neuroscience research projects that incorporate distinct technical approaches to answering common questions across SRI-supported laboratories.
The Panel also aims to develop additional tools for researchers by making novel schizophrenia-relevant genetically modified mice, to develop additional schizophrenia-relevant behaviour and cognitive tests in rodents and to create a library of schizophrenia-relevant molecular probes and antibodies.
Ultimately, the Panel aims to accelerate discovery into the cause(s) of schizophrenia.
Panel Members
Dr Jonathon Arnold, University of Sydney
Dr Nikola Bowden, University of Newcastle
Dr Murray Cairns, Schizophrenia Research Institute/University
of Newcastle
Prof. Vaughan Carr, Schizophrenia Research
Institute
Dr Vibeke Catts, Prince of Wales Medical
Research Institute
A/Prof. Loris Chahl, University of Newcastle
Ms Rose Chesworth, Schizophrenia Research Institute/Prince of Wales Medical Research Institute
Institute
Dr Victoria Dalton, Schizophrenia Research
Institute/Australian Nuclear Science and Technology Organistion
Dr Irina Dedova, Schizophrenia Research Institute/University
of Sydney
Dr Chao Deng, University of Wollongong
Mr Daren Draganic, Schizophrenia Research Institute
Ms Liesl Duffy, Schizophrenia Research Institute
Dr Elisabeth Frank, Schizophrenia Research Insititute/University of Wollongong
Dr Janice Fullerton, Prince of Wales Medical
Research Institute
Ms Mei Han, Schizophrenia Research Insititute/University of Wollongong
A/Prof. Herbert Herzog, Garvan Institute of
Medical Research
Dr Tina Hinton, University of Sydney
Prof. Xu-Feng Huang, University of Wollongong
(Co-Convenor)
Prof. Assen Jablensky, University of Western Australia
Prof. Graham Johnston, University of Sydney
Dr Tim Karl, Prince of Wales Medical Research
Institute
Dr John Kwok, Prince of Wales Medical Research
Institute
Ms Kelly Liu, Schizophrenia Research Insititute/University of Wollongong
Dr Leonora Long, Schizophrenia Research Institute/Prince of Wales Medical Research Institute
Institute
Dr Richard Morris, Prince of Wales Medical
Research Institute
Dr Kelly Newell, University of Wollongong
Dr Penny Newson, University of Newcastle
Prof. Peter Schofield, Prince of Wales Medical
Research Institute
Prof. Rodney Scott, Hunter Area Pathology Service
Prof. Cyndi Shannon Weickert, Schizophrenia
Research Institute/University of NSW/Prince of Wales Medical Research
Institute (Co-Convenor)
Dr Paul Tooney, University of Newcastle
Dr Bryce Vissel, Garvan Institute of Medical
Research
Ms Hongqin Wang, Australia Nuclear Science
and Technology Organisation
Dr Jenny Wong, Prince of Wales Medical
Research Institute
Dr Katerina Zavitsanou, Australia Nuclear Science
and Technology Organisation
Note: Please visit our research database, Brain Works, for information on every Schizophrenia Research Institute supported study.
Click here to return to Research Program.
Panel Collaborative Program
For details of the Panel's Collaborative Research Program studies, please click here
|
|
